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Ring-like N-fold Models of Aβ42 
fibrils
Wenhui Xi & Ulrich H. E. Hansmann  
When assembling as fibrils Aβ40 peptides can only assume U-shaped conformations while Aβ42 can 
also arrange as S-shaped three-stranded chains. We show that this allows Aβ42 peptides to assemble 
pore-like structures that may explain their higher toxicity. For this purpose, we develop a scalable 
model of ring-like assemblies of S-shaped Aβ1–42 chains and study the stability and structural properties 
of these assemblies through atomistic molecular dynamics simulations. We find that the proposed 
arrangements are in size and symmetry compatible with experimentally observed Aβ assemblies. We 
further show that the interior pore in our models allows for water leakage as a possible mechanism of 
cell toxicity of Aβ42 amyloids.
The brains of patients with Alzheimer’s disease are characterized by the presence of amyloid fibrils that are 
made out of amyloid-β (Aβ) peptides, most commonly Aβ1–40 peptides but also the more toxic Aβ1–42 species1–3. 
Prerequisite for the emergence of mature fibrils is the self-assembly of monomers into a seed nucleus4. In this 
process, smaller oligomers are formed that appear to be the neurotoxic agents leading to memory loss in the 
case of Alzheimer’s disease5, 6. Monomers, oligomers and amyloid fibrils exist in an equilibrium of interchanging 
structures characterized by polymorphism7–11. As differences in molecular structure correlate with cell toxicity 
and speed of disease progress, it is important to characterize the structure of amyloids11, 12. At least five different 
structures of Aβ1–40 amyloid fibrils have been resolved by solid state NMR (ss-NMR), all sharing as a common 
motif that the individual chains form two β-strands connected by a loop region7–11. The situation is more complex 
for fibrils made out of Aβ1–42 peptides. Earlier low-resolution models exhibited the same U-shape motif, shown in 
Fig. 1a, where two β-strands made of residues 18–26 and residues 31–42 are connected by a loop, and the arrange-
ment is stabilized by salt bridges between residues D23–K288. However, a number of recent studies demonstrated 
the possibility of S-shaped chain arrangements13–17, see Fig. 1b, with the N-terminal strand β1 made of residues 
12–18, the central strand β2 of residues 24–33, and the C-terminal strand β3 of residues 36–4013. Note that here, 
as in Fig. 2a and c, some N-terminal residues are not shown as the N-terminus is flexible and the structure could 
not be resolved for all its residues from the ss-NMR experiments. We have recently shown that this S-shaped 
structure is not stable in assemblies of Aβ1–40 peptides18. This is not because the lack of the β2 and β3 strand con-
necting salt bridge between the side chain of residue K28 and the main chain atoms of residue A42 that cannot be 
formed in Aβ1–40 peptides, but because of the lack of hydrophobic contacts that the C-terminal residues I41 and 
A42 form in Aβ1–42 peptides18.
It is tempting to assume that the higher toxicity of Aβ1–42 peptides is related to their ability to form this 
S-shaped motif. Such a correlation could arise if S-shaped Aβ1–42 peptides can assemble into structures that are 
either not possible, or less stable, than the assemblies formed by U-shaped Aβ chains. On first look this does not 
seem to be the case as the recently resolved S-shaped fibril structures15, 16 (Fig. 2c) have a similar two-fold packing 
as seen in the earlier determined Aβ1–42-fibrils with U-shaped chains and in most of the Aβ1–40 fibril structures 
deposited in the Protein Data Bank, see, for instance Fig. 2a. However, the only patient-derived structure in the 
Protein Data Bank has the chains arranged with a three-fold symmetry11 (Fig. 2b). Experimentally observed 
pore-like Aβ assemblies in membranes19, 20 also suggest the importance of ring-like arrangements for the disease 
mechanism. For instance, oligomers of Aβ1–42 with four to six-fold symmetry that can insert into membranes 
have been found by atomic force microscopy19, and similarly, β-barrel-like dodecamers that have pores have 
been proposed to act as ion channel in membranes20. Another example are the non-pore forming cylindrin-like 
out-of-register oligomers of Aβ21, 22 that are also toxic and related to membrane disruption. These and other 
oligomer models of Aβ that have been summarized in a recent review23 suggest looking for Aβ assemblies with 
three-fold and higher-fold symmetries as potential disease-causing agents. U-shaped Aβ chains can, because 
of steric constraints, only assemble into structures with N-fold symmetry of N ≤ 3, but the steric constraint 
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argument does not hold for S-shaped chains. Hence, Aβ1–42 peptides, being unlike Aβ1–40 peptides able to assume 
a S-shaped form, may be able to form such pore-like higher-fold assemblies, causing them to be more cytotoxic.
The experimentally determined fibrils of S-shaped Aβ1–42 peptides have a 2-fold symmetry where the chains 
are packed through inter-chain contacts between residues M35 and either L17 or Q15, see Fig. 2c15. Such packing 
of chains cannot be extended to assemblies with three and higher-fold symmetry. However, we have shown in pre-
vious work18 that S-shaped Aβ1–42 peptides can also pack by forming inter-chain salt-bridges between residue K16 
and residues E22 or D23, an arrangement that is scalable to higher-fold packing. Hence, in the present paper, we 
propose a scalable model of ring-like assemblies of S-shaped Aβ1–42 chains based on the packing proposed by us 
in our previous work18. Using molecular dynamics simulations, we investigate the stability and properties of these 
assemblies as function of size. For the case of three-fold fibril arrangements, we compare these models with the 
patient-derived Aβ1–40 fibrils which also have three-fold symmetry (Fig. 2b). We find that the proposed arrange-
ments are in size and symmetry compatible with experimentally observed fatty-acid-catalyzed oligomers and 
with pore-forming Aβ assemblies seen in membranes19, 24. We conjecture that the ability to form these arrange-
ments with high N-fold symmetry may explain the high toxicity of Aβ1–42 amyloids.
Results
Comparison of our two-fold assemblies with experimentally resolved models of Aβ42. Using 
solid-state NMR15, 16 and other experimental techniques two groups independently resolved recently Aβ1–42 fibrils 
where the individual chains take a S-shaped three-β-stranded form. These fibril models have a two-fold symmetry 
with the chains packing around residues Q15 and M35. We have shown already in Fig. 2c the structure resolved 
by Colvin T. et al.15, called by us the JACS-model. Because of steric constraints the packing in this model cannot 
Figure 1. Polymorphism in Aβ fibrils. Single fold U-shaped (a) and S-shaped (b) Aβ42 fibril chains.
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be extended to assemblies with higher fold symmetry. However, in previous work18 we have proposed, starting 
with the earlier single fold fibril model of Xiao et al.13, where the chains have the same S-shaped motif, a fibril 
assembly with two-fold symmetry that relies on contacts between residue K16 of one chain with residues E22 
and D23 of a neighboring chain. This packing, shown in Fig. 3a, can in principle be extended to assemblies with 
higher fold symmetry, but has not yet been observed in experiments. Hence, in order to test the feasibility of such 
high-fold assemblies, we first compare through molecular dynamics simulations the stability of our two-fold fibril 
model with that of the JACS model of Colvin T. et al.15 (Fig. 3c). As discussed in the method section, we restrict 
ourselves to fibril models build from Aβ11–42 chains since the first ten residues do not take a unique structure in 
experiments13 and were also found be disordered in our earlier molecular dynamic study18. For both models, we 
have generated an initial conformation with six peptides in each fold, corresponding to 12 peptides in each of the 
two models, as described in the Method section. We refer to these small assemblies as fibrils (and not oligomers) 
as we could show earlier that six chains per fold is the smallest number that leads to stable fibril-like assemblies18. 
We then follow each of the two systems in two independent molecular dynamics simulations over 200 ns. Start 
and final configurations are shown in Fig. 3. Using the MM-GBSA approximation we calculate from these runs 
estimates for the binding energies as listed in Table 1.
Both the visual inspection and the binding energies show that for fibrils with two-fold packing symmetry our 
construction is less stable than the one of the JACS model. As already described by the authors15, the inter-chain 
contact between residue M35(blue) and residues Q15(red) or L17(grey) play a key role for stability of the JACS 
model. Our calculation also indicates a large contribution of residue L34(grey), and a lesser degree of residues 
H14/V36/G37/G38 (which all have sidechains not pointing to the packing surface), to the large binding energy 
in this model. This is because in the JACS model the inter-chain sidechain contacts formed by these residues have 
better steric packing and larger interaction surface than seen in our model, leading to larger vdW contributions 
in the JACS model. The resulting lower stability of our model may explain why it has not yet been observed in 
experiments.
Comparison of our three-fold Aβ42 assembly with an experimentally derived model of Aβ40. 
Only one patient-derived fibril structure has been published so far ref. 11. This structure (PDB-ID: 2M4J), shown 
in Fig. 4a, has a three-fold symmetry and is made out of Aβ1–40 chains which cannot take a S-shaped form but 
Figure 2. Polymorphism in Aβ fibrils. Top row: Two-fold (a) and Three-fold (b) U-shaped Aβ40 fibril chains; 
bottom row: two-fold S-shaped Aβ42 fibril chains (c); higher-fold fibril arrangements have not yet been observed 
experimentally.
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have to assume a U-shaped configuration25. The side chain packing of the chains in this assembly is shown in 
Fig. 4b. It is tempting to assume that the ring-like assembly, differing from other fibril polymorphs, is connected 
with either toxicity or propagation of amyloids in Alzheimer’s disease11. However, no fibrils with three-fold sym-
metry have been found so far for the supposedly more toxic Aβ1–42. An obvious question is whether a three-fold 
structure such as the patient-derived 2M4J model can also exist for Aβ1–42 fibrils.
Taking the patient-derived 2M4J model and adding to all three chains the C-terminal residues I41 and A42 is 
because of steric constraints only possible if these residues form together with the residue V40 a β-strand, leading 
again to S-shaped chains. Depending on the direction of the side chains of the two residues I41 and A42 one can 
construct two structures which differ from the original 2M4J model in that the additional residues fill its pore-like 
interior. We show in figure Fig. 4d only the more stable one, with the side chain packing displayed in more detail 
in Fig. 4d. While the other one decayed in less than 20 ns, this one did survive the full 200 ns of our simulation, 
but became distorted, especially in the pore region (Fig. 4f), and had root-mean-square-deviations to the initial 
structure that are much larger than the ones seen in our previous simulations of the origin 2M4J model (Fig. 4c). 
We conclude that the patient-derived three-fold Aβ1–40 fibril architecture is incompatible with Aβ1–42 peptides 
because the pores are not large enough for the additional two residues.
Figure 3. Conformation of our two-fold model and the JACS model. Initial (a) and final (b) conformation 
(after 200 ns of molecular dynamics simulation) of the two-fold model of Aβ11–42 predicted by us in previous 
work18. The corresponding configurations for the two-fold model derived by Colvin T. et al.15 are shown in (c,d). 
Color map of residues: red-Q15, grey-L17/L34, blue-M35.
Interaction (kcal/mol) Our model JACS-model
vdW −10.2 (5.7) −280.3 (11.2)
E-elect −2018.1 (278.6) 66.6 (16.4)
E-GB 1968.2 (267.8) 44.7 (14.8)
E-surf −5.9 (0.8) −32.3 (0.9)
Total −66.0 (7.1) −201.4 (12.6)
Table 1. Binding energy (in kcal/mol) distribution for the two-fold model (JACS model) of ref. 15 and the one 
proposed by us in previous work18. Each fibril fragment is made of two proto-fibrils with each six layers, see 
Fig. 3ac.
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Hence, as three-fold fibril structures with U-shaped Aβ1–42 peptides are unstable and have not been observed, 
it is worthwhile to consider arrangements build from S-shaped Aβ1–42 chains. Unlike the packing of S-shaped 
chains observed in the experimentally found two-folded Aβ1–42 fibrils15, 16, our arrangement can be easily extended 
to three and higher fold symmetry. Guided by our hypothesis that the higher toxicity of Aβ1–42 is due to its abil-
ity to take a S-shaped configuration in amyloid assemblies, and assuming that ring-like assemblies (such as the 
patient-derived Aβ1–40 fibril model) are more important than other polymorphs for the pathology of Alzheimer’s 
disease, we have compared the stability and structural reorganisations of three-fold fibril models of Aβ1–40 and 
Aβ1–42. For this purpose, we have run for 200 ns two independent molecular dynamics simulations of a Aβ1–42 
fibril model with three-fold symmetry generated by us as described by us in the method section and shown in 
Fig. 4g, with the corresponding side chain packing enlarged in Fig. 4h. Note that such three-fold assembly of 
Figure 4. Conformation of three-fold models. Aβ1–40 (a) initial conformation and (c) final conformation after 
200 ns of molecular dynamics; the above packing model extended to Aβ1–42, (d) initial conformation and (f) 
final conformation after 200 ns of molecular dynamics; Aβ1–42 three-fold model with our proposed packing, (g) 
initial conformation and (i) last conformation after 200 ns of molecular dynamics; the same three-fold model, 
but for Aβ11–42, (j) initial conformation and (l) last conformation after 200 ns of molecular dynamics. The 
corresponding side chain packing of the initial conformations are also shown in detail in (b,e,h,k).
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S-shaped Aβ1–42 peptides cannot be built if one assumes the chain packing seen in the experimentally derived 
two-fold fibrils (PDB ID: 5KK3). The initial and finial conformations are shown in Fig. 4g,i. There are six layers in 
both models, and the new simulations follow a similar set-up as in our earlier work25 where we studied the stabil-
ity of the patient derived three-fold Aβ1–40 fibril. In order to allow for a meaningful comparison, we also show the 
initial (Fig. 4a) and finial conformations (Fig. 4c) for this model.
Note that while we arranged for the first ten residues of the Aβ42 peptides to form a β-strand in the start con-
formation, the β-strand secondary structure of these N-terminal residues dissolves over the 200 ns trajectories. 
However, with this exception the fibril structure remains stable, and the root-mean-square-deviation (RMSD) 
to the start configuration approaches a plateau after 50 ns as shown in the inset of Fig. 5a. On the other hand, 
the patient derived Aβ1–40 model is much more flexible than our construct, leading to higher RMSD values as 
seen in the corresponding curve in the inset of Fig. 5a. This is consistent with our previous work25, where we also 
observed a large flexibility in the three-fold patient-derived Aβ1–40 model. Various conformational characteristics 
of both models are listed in Table 2. The three-fold Aβ1–42 fibril model has a larger outer diameter (11.4 nm) than 
the patient-derived Aβ1–40 fibril (6.5 nm) which is caused by the arrangement of the N-terminal first ten residues 
in Aβ1–42 model. The inner diameter, equivalent cross-section area and water flow of the Aβ1–42 fibril are also 
larger than that of the patient-derived Aβ1–40 fibril, but the difference is smaller than for the outer diameter. We 
remark that the pore size and water permeability of our Aβ1–42 model, exceeding that of the patient-derived Aβ1–40 
fibril model, could imply a higher toxicity when acting as membrane pores.
Figure 5. RMSF and binding energy of three-fold model. (a) Root-mean-square-fluctuations (RMSF) of 
residues in the three-fold Aβ40 and Aβ42 models. The inset shows for both models the root-mean-square-
deviation (RMSD) to the start configuration as function of time. (b) Comparison of the binding energy of each 
residue for the two models.
www.nature.com/scientificreports/
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Both three-fold fibril models, the patient-derived Aβ1–40 and our proposed Aβ1–42 arrangement are stable for 
at least 200 ns, the length of our simulations. However, the root-mean-square-fluctuation (RMSF) analysis shown 
in Fig. 5a indicates that our Aβ1–42 fibril model is more stable than the patient-derived Aβ1–40 fibril, an assumption 
supported by the lower standard deviation in quantities such as equivalent cross-sectional area that are listed in 
Table 2. In the patient-derived three-fold Aβ1–40 fibril model, the first ten residues adopt a β-strand conformation 
that appears to be unstable and prone to large fluctuations. In the Aβ1–42 models, these N-terminal first ten resi-
dues have similar large fluctuations but affect less the overall stability of the fibril.
In order to learn more about the reasons for the differences in stability between the two models, we show in 
Fig. 5b the binding energy contribution of each residue as approximated by the MM-GBSA approach. In the ini-
tial conformation of patient-derived three-fold Aβ1–40 fibril model, the packing of the three parts in Fig. 4b is: first, 
residue R5 with residue D7 and V24 with S26; second, side chain of residue E11 with the backbone of residues 
G9 and N27; third, residue V39 with residue V40 and A30 with I32. For most parts, these contacts also add later 
to the binding energy. The binding energy between the fold components is more favorable in the patient-derived 
Aβ1–40 model than in the Aβ1–42 model, indicating that the stability differences do not result from contributions at 
the packing surface but from the intra-chain packing pattern. The S-shape architecture of Aβ1–42 chains is more 
stable than the U-shape form of the Aβ1–40 peptides.
Stability of our proposed N-fold Aβ42 models. Scanning tunneling microscopy (STM) and atomic 
force microscopy (AFM) measurements allow one to estimate the diameter of fibrils. For Aβ40 and Aβ42 fibrils 
this diameter varies over a broad range from 3 nm to more than 20 nm. Single fold and two-fold models can-
not describe fibrils with a diameter of larger than 10 nm, hence, the experimental data suggest that some of the 
fibrils are built from more than two protofibrils, i.e., have three and higher fold symmetry. An example is the 
patient-derived fibril model 2M4J made from U-shaped Aβ1–40 chains. In principle, its packing can be extended 
to higher fold numbers, however, this would even further reduce its stability. Unlike U-shaped Aβ1–42 peptides, 
S-shaped Aβ1–42 chains can in principle also assemble into fibrils with fold symmetry larger than three when 
packing as proposed by us. However, it is not clear whether such assemblies are stable or have desirable structural 
properties. In order to investigate these questions, we have generated a series of Aβ11–42 fibrils with three, four, five, 
six and 12-fold symmetry, and have followed their evolution in two independent molecular dynamics simulations 
of 200 ns (50 ns for the 12-fold fibril). In order to explore the role of the first ten residues, which are disordered 
in the experimental structures, on the stability of the N-fold symmetric assemblies, we have also repeated these 
simulations for full-sized Aβ1–42 with either three-fold or six-fold symmetry, using the same number of chains 
in each fibril fragment and the same simulation protocol. Analyzing these control simulations, we find that the 
first ten residues become disordered even if they are arranged initially as a β-strand, but the overall stability and 
evolution of the fibrils differ little from the corresponding Aβ11–42 fibrils. This can be seen by comparing Fig. 4g 
and i (start and final configuration for full-sized chains) with Fig. 4j and l (start and final configuration for the 
truncated peptides). Note that the side chain packing is the same for both models (Fig. 4h and j). Note also, that 
quantities such as pore size or RMSD to the start configuration are the same within the statistical errors. Hence, in 
the following we only consider Aβ11–42 fibrils as the smaller size reduces the computational costs.
All of our N-fold models are stable over the 200 ns of the trajectories (50 ns for the 12-fold fibril). From the two 
independent runs, we have chosen the final configuration with the largest RMSD to the start configuration, and 
show it for the four, five, six and 12-fold case in Fig. 6. The corresponding three-fold structure is already shown 
in Fig. 4. In all cases, the N-fold models maintain their backbone H-bonds and contacts between the packing 
surfaces.
We have calculated for each fold the RMSD of a single chain to the corresponding chain in the start configura-
tion, and have plotted that quantity as function of time in Fig. 7a. The corresponding RMSD values for the whole 
model are shown in Fig. 7b. Similar to the previously shown two-fold and three-fold models, both RMSD values 
approaches a plateau after 20 ns indicating that equilibrium has been reached. The RMSD evolution of the single 
chains in Fig. 7a resembles closely the one observed in earlier work for single-fold fibrils18. Comparing the RMSD 
of the whole models (Fig. 7b) and that of single chains (Fig. 7a), we see that the large RMSD observed for all of 
the N-fold models are caused by the relative movement between chains while the individual chains change little 
and keep their S-shape motif. For instance, in the six-fold model, each chain maintains stable during simulations, 
and the fluctuation seen in Fig. 7b is caused by the various chains changing their relative position. This can be also 
seen in Fig. 7c where we plot the distribution of the distance between the side-chains of residue K16 and residue 
E22 or D23. The peak in the two distributions indicates that the inter-chain salt-bridge persists during the simula-
tion, but as the fold number N increases, the salt-bridge between residues K16-E22 (Fig. 7c) is gradually lost and 
the distance between the two residues shifts to a value of 5 Å, while it stays at 2 Å, a value more typical for a salt 
bridge, for the distance between residues K16-D23 (Fig. 7c).
The difference in the distance distributions is related to the different binding energies per residue shown in 
Fig. 7d. Besides the inter-chain K16-E22/D23 salt-bridge, the residues Q15, V24 and G25 are also in contact with 
Models
Inner 
diameter 
(nm)
Outer 
diameter 
(nm)
Number 
of water 
molecules
Volume 
(nm3)
Equivalent 
cross-sectional 
area (nm2)
Water flow 
(nm−1)
Aβ1–42 2.0 11.4 341.1 (13.8) 10.20 (0.43) 4.10 (0.12) 87.2 (0.2)
Aβ1–40 1.7 6.5 263.6 (23.9) 7.88 (0.71) 2.99 (0.19) 77.8 (0.2)
Table 2. Comparison of three-fold models of Aβ1–40 and Aβ1–42 fibrils shown in Fig. 4.
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other chains. In the two and three-fold models, the electrostatic interactions between residues E22 and K16 are 
stronger than the ones between residues K16 and D23. In the higher fold models, the packing angles between 
the side chains of residue K16 and either residue E22 or D23 changes and the two sets of interactions have sim-
ilar strength. As these salt bridges are the essential for our proposed models, we would expect that the packing 
depends on pH or salt-concentration. On the other hand, these salt bridge could be easily detected by NMR and 
similar methods, even without resolving the structures in detail.
As discussed above, experimentally measured fibril diameters suggest the existence of fibrils with three and 
higher-fold symmetry. These measurements can be compared with the outer diameter of our models, allowing us 
to verify that our models are reasonable (i.e., are compatible with the experiments). For this purpose, we define 
the outer diameters of the N-fold models as the maximal distance between any pair of carbon-alpha atoms in the 
residues E11 of chains located in the same layer, and we show the corresponding values for the various N-fold 
models in Table 3. Note that for the six-fold models of Aβ11–42 we find a distance of about 10 nm which well agrees 
with experimental measurements of Aβ channel on membrane (13.2 nm for six-fold channel)19 or 12–24 mer of 
Aβ oligomers (11.2–14.3 nm in height)26, 27. The radial symmetry of the proposed fold models leads also to forma-
tion of an inner pore inside the fibrils whose size can be approximate by measuring in our models the maximal 
distance between any pair of carbon-alpha atoms in residues K16 of all chains in the same layer. These estimates 
are also shown in Table 3.
The pore size increases with fold number and is about 5.2 nm for six-fold models built from the full-length 
peptide Aβ1–42. Comparing with that of common water channels, for example, AQP1 which have effective pore 
diameter around 0.3–0.4 nm28, the pore inside the six-fold fibril are much more favorable of permeation. In a sim-
ilar way, the outer diameter increases with fold number to about 15.2 nm for 6-fold models of Aβ1–42, fitting well 
the experimental measurements. In both cases, the growth can be fitted by a straight line (see Fig. 8a) by
= . × + .D N N( ) 1 25 2 95 (1)outer
= . × − .D N N( ) 1 25 2 25 (2)inner
Here Douter (Dinner) is the outer (inner) diameters of fibrils, and N is the fold number of the models. We expect 
that the slope of the scaling relations for the two diameter is the same for sufficiently large N. For this reason, 
Figure 6. Final conformations of Aβ11–42 N-fold fibril models after molecular dynamics simulations of 200 ns 
(50 ns in the case of the 12-fold model). The side chains of K16, E22 and D23 are shown as vdW spheres.
www.nature.com/scientificreports/
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we have fit our data with the same slope. Note, that we did not use our 12-fold data for the fit, allowing us to 
use these points to check the predictive power of our fit. According to our fitting equation, for the N = 12 fold, 
the outer diameter will be 18 nm, and the inner diameter will be 12.8 nm. In order to check the prediction, we 
constructed the 12-fold models of Aβ11–42 and perform a 50 ns molecular dynamics run. The final configuration 
is shown in Fig. 8c. The fibril kept stable in such time scale and we find values of 11.5 nm for the inner diameter 
and 17.4 nm for the outer diameter. As also seen in the scaling plot in Fig. 8a, the 12-fold data are compatible with 
the fit, but the simple linear fit seems to overestimate the diameters. This is because the cross-sectional area of the 
N-fold models is better described by an ellipse than a circle, and leading to deviations from the linear function 
on higher fold numbers. This break down of the fitting relation may actually indicate that there is an optimal size 
of our N-fold assemblies. In order to demonstrate this point, we show in Fig. 8b for the six-fold model the dom-
inant inter-layer interactions (linked by black line). Their curvature can be described by an angle of about 28–34 
degrees, which suggests that the best packing N-fold models would be 11–13-mers and would have a radius of 
curvature of about 5–6 nm. This assumption seems to be supported by our results from the 12-fold simulation. 
For instance, the β1 section and turn1 section on adjacent peptides form contacts that are in all twelve compo-
nents better than seen in the five-fold and six-fold models. Interestingly, unlike the six-fold model which has an 
elliptical pore, the 12-fold model has a nearly circular pore which varies less than 1 nm along the 50 ns trajectory. 
However, these simulations may be too short to examine rigorously the stability of the 12-fold model. We also 
remark that for the full length Aβ1–42 chains, the outer diameters would be 5 nm larger than for the Aβ11–42 pep-
tides, leading to an outer diameter of about 23–24 nm for 12-fold Aβ1–42 fibrils. i.e., diameters that are at the upper 
range of the experimental measurements.
Figure 7. Conformation characteristics and binding energy of N-fold model. RMSD with respect to the start 
configuration as function of time for a single chain (a) and the whole model (b). The minimal distance between 
corresponding inter-chain residues K16 and D23, with the insert showing the distance between residues K16 
and E22 (c). Binding energy decomposition of each residue between different chains in N-fold models (d).
Models Inner diameter (nm) Outer diameter (nm)
3-fold 1.9 6.3
4-fold 2.5 8.3
5-fold 3.9 9.1
6-fold 5.2 10.6
12-fold 11.8 17.3
Aβ1–42: 3-fold 2.0 11.4
Aβ1–42: 6-fold 5.1 15.2
Table 3. Inner and outer diameters of our N-fold fibril models as defined in the text.
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All of our models are built out of six layers. The height of fibrils along the z-axis (shown in Fig. 9a) are similar 
in all models. For example, the average height of fibrils in three-fold models is about 2.5 nm, where we define the 
height as the average distance between corresponding carbon-alpha atoms of residues in the first and sixth layer. 
The average distance between two peptides in our models is about 5 Å, which is a common value for the distance 
between the main chains of two peptides in a parallel β-sheet. Since the cross-sectional area is not regular, it is 
hard to calculated it directly. Instead, we have estimated the volume of the pores from the number of water mole-
cules number inside it (shown in Table 4), assuming that the average occupied volume of each water molecule is 
about 2.99 × 10−2 nm3 at room temperature, and divided the so-calculated volume by the height of the fragment 
to derive the equivalent cross-sectional areas that are shown in Table 4.
Note that the diameters of the pores in our models are larger than some of the ion channel, for example, that 
of potassium channels which are about 1.2 nm29, 30, suggesting water leakage through such fibrils inserted in cell 
membranes as a possible toxicity mechanism. If such N-fold fibrils insert themselves into the membrane, they 
Figure 8. Outer and inner diameters. (a) The outer and inner diameters of N-fold models and the 
corresponding fit as function of fold number. (b) Curvature of the adjacent fold component in the six-fold 
model. (c) The final confirmation of the 12-fold model after 50 ns of molecular dynamics simulation, and its 
inner and its outer diameters.
Figure 9. Pores and water flow. (a) Cross-sectional area of the inner pores in our N-fold models. (b) The cross-
sectional area of pores and water flow in our N-fold fibril models.
Models
Number of water 
molecules Volume (nm3)
Equivalent cross-
sectional area (nm2)
Water flow 
(nm−1)
Three-fold 338.5 (15.7) 10.12 (0.47) 4.08 (0.12) 85.4 (1.2)
Four-fold 438.39 (13.20) 13.11 (0.39) 5.28 (0.10) 172.4 (0.8)
Five-fold 533.0 (15.9) 15.9 (0.5) 6.4 (0.1) 297.3 (8.2)
Six-fold 568.6 (10.9) 17.0 (0.3) 6.9 (0.1) 454.4 (6.4)
Aβ40 Three-fold 263.6 (23.9) 7.9 (0.7) 3.0 (0.2) 77.8 (0.2)
Table 4. Average number of water molecules in pores and the equivalent cross-sectional area as measured in 
our Aβ11–42 fibril models.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7: 6588 | DOI:10.1038/s41598-017-06846-0
would form pores that disrupt the osmotic pressure of membranes. The thickness of a typical bilayer lipid is about 
3–4 nm which means an N-fold fibril with 6–8 layers could cross it as the distance between opposite residues in 
β-strand is about 5 Å. In order to estimate the effectiveness of such pores we have also calculated the water flow in 
our models, where the pores are defined as described above, and only water molecules crossing through the fibril 
either upwards or downwards are counted. The average number of water molecules permeating through the pores 
per nanosecond is shown for each model in Table 4. The relationship between cross-section area and water flow 
are plotted in Fig. 9b. As expected, we find that the larger of the pores, the better is permeation. And the water 
flow is a quadratic function of pore size.
Previous AFM experiments have probe the structures of Aβ42 channels in membranes19. Interestingly, not 
a single kind pores was found, but channels with three, four, five and six subunits are observed. The measured 
diameter for channels made of four subunits is 11.5 nm and 18.1 nm for channels made of five subunits. These 
values are compatible with the outer diameters of the corresponding N-fold models developed by us. Hence, 
our ring-like assemblies may serve as models for the experimentally observe neurotoxic Aβ42 channels in mem-
branes19, 31. Note, however, that the structure of these assemblies is difficult to resolve in experiments, and other 
models, such as beta-barrels have been proposed for the N-subunits Aβ42 channels19, 32, with no evidence in favor 
of either model. We also remark that our three-fold model with four layers is compatible in height and size with 
the neurotoxic oligomers of Aβ42 called large fatty acid derived oligomers(LFAOs)33, 34 that consist of 12 or 24 
peptides and have a height of about 5–7 nm.
Discussion
The research presented in this article is guided by two hypothesizes. First, we conjecture that the higher toxic-
ity of Aβ42 when compared to that of Aβ40 is due to the ability of Aβ42 peptides to assemble not only into fibrils 
made of U-shaped chains but in addition also in such build out of three-stranded S-shaped chains. Our second 
assumption is that toxicity of amyloids is related to them forming pore-like structures. In the present paper, we 
demonstrate that S-shaped Aβ42 peptides can indeed assemble into ring-like structures that are stable over the 
length of our molecular dynamic simulations.
Our proposed models rely on a chain packing that is stabilized by inter-chain salt bridges between residues 
K16 and either E22 or D23. This packing is energetically less favorable than the one stabilized by contacts between 
residues Q15 and M35 that has been observed in the experimentally resolved Aβ42 fibrils with two-fold symme-
try15, 16. In passing, we remark that the two binding forms could be compatible. One could imagine a protofibril to 
be formed by Q15-M35 contacts, and assemble with two other such protofibrils through inter chain salt bridges 
formed between residues E22 and D23 or K16 that would lead two fibrils growing not only along the fibril axis 
but also perpendicular to it which may open applications for the design of new materials. We have not pursued 
this idea and instead focused on the main advantage of our proposed packing through inter-chain salt bridges 
between residues K16 and either E22 or D23, namely that it is not sterically constraint two two-fold assem-
blies. Three and higher fold assemblies with our chain packing lead naturally to pore-like structures. Geometrical 
considerations suggest 12-fold models as the optimal arrangement, however, already our three-fold Aβ1–42 fibril 
model is more stable than the patient-derived Aβ1–40 fibril model (PDB-Id: 2M4J) that has the same three-fold 
symmetry. Similarly, N-fold assemblies with N = 4, 5, 6 and 12 are also stable and have outer diameters that are 
comparable with some of previous experimental measurements of fibril diameters. As our assemblies are charac-
terized by a unique pattern of inter-chain sidechain electrostatic interactions between residues K16 and either E22 
or D23, they could be experimentally identified by the resulting specific NMR signal. We also suspect that fibrils 
with our arrangement would have a strong response to changes salt concentration or pH.
All of our ring-like N-fold fibril models have an interior pore through which water can flow, suggesting as 
mechanism of cell toxicity membrane leaking when the fibrils are inserted into bilayer lipids. In size and bio-
physical characteristics they are consistent with neurotoxic Aβ42 channels observed with AFM experiments in 
membranes19, 31, 35. We conjecture that our three-fold model with four layers could serve as a model for the 12–24 
residue large fatty acid derived oligomers(LFAOs)33, 34 whose neurotoxicity has been recently shown in both cell 
culture33 and in a mice brains36. We now plan to test this hypothesis experimentally in a collaboration with the 
Ranagchari Lab that we hope to start soon. We emphasize that our N-fold models are different from previous 
β-barrel models of Aβ peptides19, 32 and point out another possible mechanism for toxicity of Aβ42 fibrils or oli-
gomers. As Aβ40 peptides cannot assume the triple β-strand motif, they cannot form the pore-like N-fold fibril 
structures that we have proposed in this study. This difference therefore could explain the higher toxicity of Aβ42 
amyloids over that of Aβ40.
Our investigation touches a general problem in amyloid studies, namely the role of polymorphism. In order 
to minimize the exposed hydrophobic surface, the Aβ-chains have to collapse into U-shaped or S-shaped packing 
conformations leading already to a plethora of polymorphic structures37. However, through domain-swapping 
the peptides can also adopt extended conformations and hide the hydrophobic regions into the packing surface17. 
The domain-swapping region located on C-terminal region of Aβ42 and it formed three extended β-sheet-like 
section (15–22, 28–36 and 39–42)17 which is similar with the Aβ42 S-shape model13. The domain-swapping model 
would have great hydrophobic exposed area in single-fold condition, which is differs from the JACS model that 
the fibril could also be existed in single-fold S-shape conformation. The variations in architectures of two-fold 
models suggest that high-fold model of fibrils are not just simple rotation and combination of stable single-fold 
fibril models, for example, U-shape or S-shape in Aβ42 fibrils. We cannot exclude the possibility that the resolved 
fibril models are just particular cases, and that there are multifarious mechanisms of forming high-fold fibrils 
instead of a unique one.
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Methods
Model construction. In our previous work18, we have proposed that the newly found S-shaped Aβ1–42 pep-
tides can form two-fold fibrils by packing two chains in such a way that an inter chain salt bridge between residue 
K16 and residues E22 or D23 is formed. This packing pattern, called PSA by us, can be extent to fibrils with high-
er-fold rotational symmetry. For the present study, we build three, four, five, six and 12-fold models of S-shaped 
Aβ11–42 fibril models with six peptides in each layer. While these assemblies are technically not fibrils but oli-
gomers, we use the term “fibril” throughout this paper as we found earlier that six chains is the minimal number 
that leads to stable single-fold fibril-like assemblies18. Focusing on residues 11 to 42 is justified because the first 
ten residues do not take a unique structure in experiments13 and were also found be disordered in our earlier 
molecular dynamic study18. However, in order to exclude any bias resulting from omitting the first ten residues, 
we have also constructed high-fold models built out of full-length Aβ1–42 peptides, specifically, three-fold and six-
fold models where the first ten residues adopt a β-strand conformation. As our molecular dynamic simulations of 
these two systems (see Result section) showed that the first ten become quickly disordered, we used for all other 
simulations the shorter and computationally less costly Aβ11–42 fibril models.
All our N-fold fibrils are built using AmberTools38 as follows: first, we selected from our previous molecu-
lar dynamics work18 a representative conformation of a single-fold S-shape Aβ11–42 fibril fragment. Second, this 
six-layer fragment was replicated and, through rotation and translations, the protofibril fragments arranged in a 
way that residue K16 is close to residues E22 or D23 of another chain. The resulting n-fold structures were mini-
mized in a third step and allowed to relax in 10 ns molecular dynamics simulation using Amber1438, restraining 
the inter- chain contacts between residue K16 and residues E22 and D23. The so-obtained structures were chosen 
as start configurations for our molecular dynamics simulations. The procedure was similar for the Aβ1–42 fibril 
models, only that in the first step also the first ten residues were added to each chain, assuming a perfect β-strand 
configuration.
Using more recent experimental results, two other groups also developed two-fold models of S-shape Aβ4215, 16. 
For this reason, we compare our two-fold model also with the two-fold Aβ11–42 fibril model (PDB ID: 5KK3) 
developed by Colvin T. et al. which we name JACS-model in our present work. For this purpose, the PDB struc-
ture was truncated to a six-layer system comparable to our other models and studied in our simulations with the 
same parameters and setup.
Molecular dynamics simulation. Our simulations rely on the GROMACS 4.6.7 tool suit39, using the 
CHARMM 36 force field40 and TIP3P solvent41. For each model, two independent trajectories are followed 
for 200 ns, starting from the same initial conformation but different, randomly chosen initial velocities corre-
sponding to a temperature of 310 K. This temperature and a pressure of 1 bar are controlled by v-rescale ther-
mostat42 and Parrinello-Rahman barostat43. The LINCE algorithm44, SETTLE algorithm45 are employed 
for bonds so that the time step of 2 fs are used for integration. The particle mesh Ewald(PME) method46 are 
used to calculated electrostatic interactions. The cutoff of van der Waals(vdW) and electrostatic interactions 
are 1.4/1.0 nm. For 3/4/5/6-fold of Aβ11–42 fibrils, the cubic boxes are used and the corresponding box size are 
9.86/10.70/11.43/12.74 nm. The boxes are large enough so that the peptides do not have direct interactions with 
their images.
Since the 12-fold model contains 2304 residues, we tried to minimize the computational costs by choosing a 
triclinic box with periodic boundary conditions, constraining the fibril rang into x-y plane with a weak position 
restraint of 12.0 kJ/nm on z-axis for carbon alpha of all valine residues. This restraint ensured that the fibril did 
not have direct contact or electrostatic interaction with its image and greatly reduced the box size and number of 
water molecules, but we still had to restrict our simulations of this system to 50 ns.
In order to exclude force field related biases, and to connect with our earlier work18, we have also simulated 
the three-fold model with the same set-up, but using the Amber ff99SB-ildn force field47. As the simulations of 
this system differed little from the one using CHARMM36, we used only the later in all other of our simulations.
For most of our analysis we discard the first 50 ns of our simulations and the presented data are averaged over 
the remaining 150 ns and two trajectories. The binding energies are approximated through MM-GBSA using the 
MMGBSA.py tools48 in Amber 14, where we employ the generalized Born (GB) model developed by H. Nguyen 
et al.49 and do not consider entropic contributions. The water flow analysis is carried out with an in-house plugin 
to VMD that has been developed in our group and is available from the authors.
Data Availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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